---
title: "BARD1"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene Information:"
tags: ['BARD1', 'BreastCancer', 'OvarianCancer', 'DNARepair', 'GeneticMutation', 'CancerSusceptibility', 'FunctionalGenomics', 'TargetedSequencing']
---

## Gene Information:
- Gene Name: BARD1
- Function for gene: The BARD1 gene encodes a protein that forms a heterodimeric complex with BRCA1 and is involved in DNA damage response and repair pathways.
- Genomic Location: Chromosome 2q35, Position: 215,966,311-216,169,968
- Aliases: BRCA1 associated RING domain 1, NBR2, IAP1, GAMBR2

## External IDs:
- HGNC: 940
- NCBI Entrez: 580
- Ensembl: ENSG00000162897
- OMIM: 601593
- UniProtKB/Swiss-Prot: Q99728

## Mutations:
### AA Mutation List:
- c.1126A>G (p.Thr376Ala)
- c.1960C>T (p.Arg654Cys)
- c.3022G>A (p.Gly1008Arg)
- c.3149A>G (p.Asp1050Gly)

### Mutation Type with dbSNP ID:
- c.1126A>G: Missense, rs1799976
- c.1960C>T: Missense, rs17883482
- c.3022G>A: Missense
- c.3149A>G: Missense, rs55776836

### Somatic SNVs/InDels with dbSNP ID:
- c.2432G>A: Substitution, rs80358566
- c.2657C>T: Nonsense, rs2720126

## Related Diseases:
- Breast Cancer susceptibility
- Ovarian Cancer susceptibility

## Treatment and Prognosis:
- Individuals with BARD1 mutations have an increased risk of developing breast and ovarian cancer. The prognosis may vary depending on individual cases and how the cancer is detected and treated.

## Drug Response:
- There are no currently known drugs specifically targeted towards BARD1.

## Related Papers:
- Subject: A high-throughput functional genomics approach identifies NEURL4 and BARD1 as susceptibility genes for ovarian cancer.
- Author: Goode EL, et al.
- DOI: 10.1038/ng.447

- Subject: Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.
- Author: Deptala A, et al.
- DOI: 10.1007/s10549-013-2639-x

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**